Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.

Patterns of pharmacotherapy for bipolar disorder: A GBC survey.

Autor: Singh B; Mayo Clinic, Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA., Yocum AK; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA., Strawbridge R; Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Burdick KE; Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA., Millett CE; Harvard Medical School, Brigham and Women's Hospital, Boston, Massachusetts, USA., Peters AT; Dauten Family Center for Bipolar Treatment Innovation, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA., Sperry SH; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA., Fico G; Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain., Vieta E; Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain., Verdolini N; Bipolar and Depressive Disorders Unit, Institute of Neuroscience, Hospital Clinic, University of Barcelona, IDIBAPS, CIBERSAM, Barcelona, Catalonia, Spain.; Local Health Unit Umbria 1, Department of Mental Health, Mental Health Center of Perugia, Perugia, Italy., Godin O; INSERM U955, IMRB, Translational Neuro-Psychiatry, Fondation FondaMental, Univ Paris Est Créteil, Créteil, France.; Département Médico-Universitaire de Psychiatrie et d'Addictologie (DMU IMPACT), APHP, Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Créteil, France., Leboyer M; INSERM U955, IMRB, Translational Neuro-Psychiatry, Fondation FondaMental, Univ Paris Est Créteil, Créteil, France.; Département Médico-Universitaire de Psychiatrie et d'Addictologie (DMU IMPACT), APHP, Hôpitaux Universitaires Henri Mondor, Fédération Hospitalo-Universitaire de Médecine de Précision en Psychiatrie (FHU ADAPT), Créteil, France., Etain B; Groupe Hospitalo-universitaire AP-HP Nord, DMU Neurosciences, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, INSERM UMRS 1144, Université de Paris, AP-HP, Paris, France., Tso IF; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA.; Department of Psychiatry & Behavioral Health, The Ohio State University, Columbus, Ohio, USA., Coombes BJ; Department of Quantitative Health Sciences, Mayo Clinic, Rochester, Minnesota, USA., McInnis MG; Department of Psychiatry, University of Michigan, Ann Arbor, Michigan, USA., Nierenberg AA; Dauten Family Center for Bipolar Treatment Innovation, Harvard Medical School, Massachusetts General Hospital, Boston, Massachusetts, USA., Young AH; Department of Psychological Medicine, Institute of Psychiatry, Psychology & Neuroscience, King's College London, London, UK., Ashton MM; IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia., Berk M; IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia.; Orygen, The National Centre of Excellence in Youth Mental Health, Centre for Youth Mental Health, Florey Institute for Neuroscience and Mental Health and the Department of Psychiatry, The University of Melbourne, Melbourne, Victoria, Australia., Williams LJ; IMPACT - the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Victoria, Australia., Keramatian K; Department of Psychiatry, University of British Columbia, Vancouver, Canada., Yatham LN; Department of Psychiatry, University of British Columbia, Vancouver, Canada., Overs BJ; Neuroscience Research Australia, Randwick, Sydney, New South Wales, Australia., Fullerton JM; Neuroscience Research Australia, Randwick, Sydney, New South Wales, Australia.; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Roberts G; School of Psychiatry, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Mitchell PB; School of Medical Sciences, Faculty of Medicine, University of New South Wales, Sydney, New South Wales, Australia., Andreassen OA; NORMENT Centre, Division of Mental Health and Addiction, University of Oslo and Oslo University Hospital, Oslo, Norway., Andreazza AC; Department of Pharmacology & Toxicology, Temerty Faculty of Medicine, University of Toronto, Toronto, Canada., Zandi PP; Department of Psychiatry and Behavioral Sciences, Johns Hopkins School of Medicine, Baltimore, Maryland, USA., Pham D; The Milken Institute, Washington, District of Columbia, USA., Biernacka JM; Mayo Clinic, Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA.; Groupe Hospitalo-universitaire AP-HP Nord, DMU Neurosciences, Hôpital Fernand Widal, Département de Psychiatrie et de Médecine Addictologique, INSERM UMRS 1144, Université de Paris, AP-HP, Paris, France., Frye MA; Mayo Clinic, Department of Psychiatry & Psychology, Mayo Clinic, Rochester, Minnesota, USA.

Publikováno v: Bipolar disorders [Bipolar Disord] 2024 Feb; Vol. 26 (1), pp. 22-32. Date of Electronic Publication: 2023 Jul 18.

The Impact of N -acetylcysteine on Major Depression: Qualitative Observation and Mixed Methods Analysis of Participant Change during a 12-week Randomised Controlled Trial.

Autor: Russell SE; IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Barwon Health, Geelong, Australia., Skvarc DR; School of Psychology, Faculty of Health, Deakin University, Geelong, Australia., Mohebbi M; Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Australia., Camfield D; School of Psychology, Faculty of Health, Deakin University, Geelong, Australia., Byrne LK; School of Psychology, Faculty of Health, Deakin University, Geelong, Australia., Turner A; IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Barwon Health, Geelong, Australia., Ashton MM; IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Barwon Health, Geelong, Australia., Berk M; IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Barwon Health, Geelong, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Australia.; Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital, Parkville, Australia.; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia., Dodd S; IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Barwon Health, Geelong, Australia.; Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital, Parkville, Australia.; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia., Malhi GS; Discipline of Psychiatry, Sydney Medical School, The University of Sydney, Sydney, Australia.; CADE Clinic, Department of Psychiatry, Royal North Shore Hospital, St Leonards, Australia., Cotton SM; Department of Psychiatry, University of Melbourne, Royal Melbourne Hospital, Parkville, Australia.; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Australia., Bush AI; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Australia., Dean OM; IMPACT-the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Deakin University, Barwon Health, Geelong, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Australia.

Publikováno v: Clinical psychopharmacology and neuroscience : the official scientific journal of the Korean College of Neuropsychopharmacology [Clin Psychopharmacol Neurosci] 2023 May 30; Vol. 21 (2), pp. 320-331.

Adjunctive minocycline for major depressive disorder: A sub-study exploring peripheral immune-inflammatory markers and associated treatment response.

Autor: Walker AJ; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia., Mohebbi M; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.; Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Australia., Maes M; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand.; Department of Psychiatry, Medical University of Plodiv, Plodiv, Bulgaria., Berk M; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Australia.; Department of Psychiatry, University of Melbourne, Parkville, Australia.; Orygen, National Centre of Excellence in Youth Mental Health, Parkville, Australia., Walder K; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia., Bortolasci CC; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia., Liu ZS; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia., Ng CH; The Melbourne Clinic, Department of Psychiatry, University of Melbourne, Richmond, Australia., Ashton MM; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia., Berk L; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia., Singh AB; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia., Malhi GS; CADE Clinic and Department of Psychiatry, Royal North Shore Hospital, The University of Sydney, Sydney, Australia., Dean OM; Deakin University, IMPACT, The Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Geelong, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Australia.

Publikováno v: Brain, behavior, & immunity - health [Brain Behav Immun Health] 2022 Dec 24; Vol. 27, pp. 100581. Date of Electronic Publication: 2022 Dec 24 (Print Publication: 2023).

Exploring interleukin-6, lipopolysaccharide-binding protein and brain-derived neurotrophic factor following 12 weeks of adjunctive minocycline treatment for depression.

Autor: Hasebe K; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia.; School of Medical Sciences, UNSW Sydney, Sydney, NSW, Australia., Mohebbi M; Biostatistics Unit, Faculty of Health, Deakin University, Geelong, Vic, Australia., Gray L; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia.; Centre for Medical and Molecular Research, School of Medicine, Deakin University, Geelong, Vic, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Vic, Australia., Walker AJ; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia., Bortolasci CC; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia.; Centre for Medical and Molecular Research, School of Medicine, Deakin University, Geelong, Vic, Australia., Turner A; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia.; School of Medicine and Public Health, Faculty of Health, The University of Newcastle, Callaghan, NSW, Australia., Berk M; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Vic, Australia.; Department of Psychiatry, Royal Melbourne Hospital, University of Melbourne, Parkville, Vic, Australia.; Orygen, The National Centre of Excellence in Youth Mental Health, Parkville, Vic, Australia.; Centre of Youth Mental Health, The University of Melbourne, Parkville, Vic, Australia., Walder K; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia.; Centre for Medical and Molecular Research, School of Medicine, Deakin University, Geelong, Vic, Australia., Maes M; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Kanchanatawan B; Department of Psychiatry, Faculty of Medicine, Chulalongkorn University, Bangkok, Thailand., Ashton MM; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia., Berk L; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia.; Melbourne School of Population and Global Health, University of Melbourne, Carlton, Vic, Australia., Ng CH; Department of Psychiatry, University of Melbourne, The Melbourne Clinic, Richmond, Vic, Australia., Malhi GS; Faculty of Medicine and Health, Northern Clinical School, Department of Psychiatry, The University of Sydney, Sydney, NSW, Australia.; Academic Department of Psychiatry, Royal North Shore Hospital, Northern Sydney Local Health District, St Leonards, NSW, Australia.; CADE Clinic, Department of Psychiatry, Royal North Shore Hospital, St Leonards, NSW, Australia., Singh AB; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia., Dean OM; IMPACT, the Institute for Mental and Physical Health and Clinical Translation, School of Medicine, Barwon Health, Deakin University, Geelong, Vic, Australia.; Florey Institute for Neuroscience and Mental Health, University of Melbourne, Parkville, Vic, Australia.

Publikováno v: Acta neuropsychiatrica [Acta Neuropsychiatr] 2022 Aug; Vol. 34 (4), pp. 220-227. Date of Electronic Publication: 2021 Dec 23.